secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001193805-22-001719
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus appoints former Merck Global Vaccines President John Markels to board
------------------------------------------------------------------------------

- John Markels, Ph.D., appointed to Board of Directors effective December 8, 2022.
- Markels most recently President of Global Vaccines at Merck; retired March 2022 after 35 years.
- He will provide strategic oversight to Arcturus' vaccine franchise and manufacturing processes.
- Markels also serves on the board of Sangamo Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380522001719/0001193805-22-001719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380522001719/e618121_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-22-001719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer